During Shanghai Visit PhRMA Chairman Calls For Regulatory Systems To Support Innovation
This article was originally published in PharmAsia News
Executive Summary
During a three-day visit in Shanghai, PhRMA Chairman Robert Hugin met local stakeholders and outlined the organization’s advocacy priorities in China amidst the evolving Drug Administration Law.